| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.066 | 0.03 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.03 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |